Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 14, 2024

BUY
$113.24 - $131.95 $73.8 Million - $85.9 Million
651,299 New
651,299 $85.9 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $23.4 Million - $27.3 Million
-206,672 Reduced 24.09%
651,299 $85.9 Million
Q4 2023

Aug 15, 2024

BUY
$100.18 - $109.02 $86 Million - $93.5 Million
857,971 New
857,971 $93.5 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $33.1 Million - $36 Million
330,598 Added 62.69%
857,971 $93.5 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $34.1 Million - $37.2 Million
-314,149 Reduced 37.33%
527,373 $60.9 Million
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $24.5 Million - $27.4 Million
238,166 Added 39.47%
841,522 $89.5 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $1.74 Million - $2.23 Million
19,888 Added 3.41%
603,356 $66.9 Million
Q3 2022

Nov 08, 2022

BUY
$84.53 - $94.96 $18.8 Million - $21.1 Million
222,507 Added 61.64%
583,468 $50.2 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $30.1 Million - $34.2 Million
360,961 New
360,961 $32.9 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $13.7 Million - $15.2 Million
-190,559 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $19.1 Million - $21.6 Million
-260,619 Reduced 57.76%
190,559 $15.8 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $888,489 - $1.01 Million
-12,617 Reduced 2.72%
451,178 $34.9 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $14.1 Million - $19.6 Million
222,989 Added 92.6%
463,795 $35.7 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $18.7 Million - $21.1 Million
240,806 New
240,806 $21.9 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.